<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37241210</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Comorbidities: Linked by Vascular Pathomechanisms and Vasoactive Mediators?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">978</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina59050978</ELocationID><Abstract><AbstractText>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is often associated with various other syndromes or conditions including mast cell activation (MCA), dysmenorrhea and endometriosis, postural tachycardia (POTS) and small fiber neuropathy (SFN). The causes of these syndromes and the reason for their frequent association are not yet fully understood. We previously published a comprehensive hypothesis of the ME/CFS pathophysiology that explains the majority of symptoms, findings and chronicity of the disease. We wondered whether some of the identified key pathomechanisms in ME/CFS are also operative in MCA, endometriosis and dysmenorrhea, POTS, decreased cerebral blood flow and SFN, and possibly may provide clues on their causes and frequent co-occurrence. Our analysis indeed provides strong arguments in favor of this assumption, and we conclude that the main pathomechanisms responsible for this association are excessive generation and spillover into the systemic circulation of inflammatory and vasoactive tissue mediators, dysfunctional &#x3b2;2AdR, and the mutual triggering of symptomatology and disease initiation. Overall, vascular dysfunction appears to be a strong common denominator in these linkages.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wirth</LastName><ForeName>Klaus J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Institute of General Pharmacology and Toxicology, University Hospital Frankfurt am Main, Goethe-University, Theodor-Stern Kai 7, D-60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;hn</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of General Pharmacology and Toxicology, University Hospital Frankfurt am Main, Goethe-University, Theodor-Stern Kai 7, D-60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004412" MajorTopicYN="N">Dysmenorrhea</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004715" MajorTopicYN="Y">Endometriosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MCA</Keyword><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">cerebral blood flow</Keyword><Keyword MajorTopicYN="N">dysmenorrhea</Keyword><Keyword MajorTopicYN="N">endometriosis</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">orthostatic intolerance</Keyword><Keyword MajorTopicYN="N">small fiber neuropathy</Keyword><Keyword MajorTopicYN="N">&#x3b2;2-adrenergic receptors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37241210</ArticleId><ArticleId IdType="pmc">PMC10224216</ArticleId><ArticleId IdType="doi">10.3390/medicina59050978</ArticleId><ArticleId IdType="pii">medicina59050978</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carruthers B.M., Van De Sande M.I., De Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., et al. Myalgic encephalomyelitis: International Consensus Criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Holtzman C.S., Sunnquist M., Cotler J. The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome. J. Health Psychol. 2021;26:238&#x2013;248. doi: 10.1177/1359105318805819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105318805819</ArticleId><ArticleId IdType="pmc">PMC7988339</ArticleId><ArticleId IdType="pubmed">30354489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)&#x2014;A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors. 2021;47:232&#x2013;241. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against &#x3b2;2-adrenergic receptors. Autoimmun. Rev. 2020;19:102527. doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType="pubmed">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Boneva R.S., Lin J.-M.S., Wieser F., Nater U.M., Ditzen B., Taylor R.N., Unger E.R. Endometriosis as a Comorbid Condition in Chronic Fatigue Syndrome (CFS): Secondary Analysis of Data From a CFS Case-Control Study. Front. Pediatr. 2019;7:195. doi: 10.3389/fped.2019.00195.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00195</ArticleId><ArticleId IdType="pmc">PMC6537603</ArticleId><ArticleId IdType="pubmed">31179251</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho Y.J., Lee S.H., Park J.W., Han M., Park M.J., Han S.J. Dysfunctional signaling underlying endometriosis: Current state of knowledge. J. Mol. Endocrinol. 2018;60:R97&#x2013;R113. doi: 10.1530/JME-17-0227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JME-17-0227</ArticleId><ArticleId IdType="pubmed">29330150</ArticleId></ArticleIdList></Reference><Reference><Citation>Signorile P.G., Cassano M., Viceconte R., Marcattilj V., Baldi A. Endometriosis: A Retrospective Analysis of Clinical Data from a Cohort of 4083 Patients, with Focus on Symptoms. In Vivo. 2022;36:874&#x2013;883. doi: 10.21873/invivo.12776.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.12776</ArticleId><ArticleId IdType="pmc">PMC8931881</ArticleId><ArticleId IdType="pubmed">35241545</ArticleId></ArticleIdList></Reference><Reference><Citation>DiBenedetti D., Soliman A.M., Gupta C., Surrey E.S. Patients&#x2019; perspectives of endometriosis-related fatigue: Qualitative interviews. J. Patient-Rep. Outcomes. 2020;4:33. doi: 10.1186/s41687-020-00200-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-020-00200-1</ArticleId><ArticleId IdType="pmc">PMC7203274</ArticleId><ArticleId IdType="pubmed">32377820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P.C., Underhill R.A., Friedman K.J., Gurwitt A., Medow M.S., Schwartz M.S., Speight N., Stewart J.M., Vallings R., Rowe K.S. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Front. Pediatr. 2017;5:121. doi: 10.3389/fped.2017.00121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00121</ArticleId><ArticleId IdType="pmc">PMC5474682</ArticleId><ArticleId IdType="pubmed">28674681</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit N.M., Churchill A., Nsair A., Hsu J.J. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am. Heart J. Plus Cardiol. Res. Pract. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., L&#xf6;hn M. Orthostatic Intolerance after COVID-19 Infection: Is Disturbed Microcirculation of the Vasa Vasorum of Capacitance Vessels the Primary Defect? Medicina. 2022;58:1807. doi: 10.3390/medicina58121807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58121807</ArticleId><ArticleId IdType="pmc">PMC9788017</ArticleId><ArticleId IdType="pubmed">36557009</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Brinth L., Hendrickson J.E., Martinez-Lavin M. Autonomic dysfunction and HPV immunization: An overview. Immunol. Res. 2018;66:744&#x2013;754. doi: 10.1007/s12026-018-9036-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-018-9036-1</ArticleId><ArticleId IdType="pubmed">30478703</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttgereit T., Gu S., Carneiro-Le&#xe3;o L., Gutsche A., Maurer M., Siebenhaar F. Idiopathic mast cell activation syndrome is more often suspected than diagnosed&#x2014;A prospective real-life study. Allergy. 2022;77:2794&#x2013;2802. doi: 10.1111/all.15304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15304</ArticleId><ArticleId IdType="pubmed">35364617</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashauri H.L. COVID-19 Histamine theory: Why antihistamines should be incorporated as the basic component in COVID-19 management? Health Sci. Rep. 2023;6:e1109. doi: 10.1002/hsr2.1109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1109</ArticleId><ArticleId IdType="pmc">PMC9903129</ArticleId><ArticleId IdType="pubmed">36778771</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu C., Fuhler G.M., Pan Y. Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Int. J. Mol. Sci. 2021;22:5672. doi: 10.3390/ijms22115672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115672</ArticleId><ArticleId IdType="pmc">PMC8199351</ArticleId><ArticleId IdType="pubmed">34073529</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M.D., Lambert N., Downs C.A., Abrahim H., Hughes T.D., Rahmani A.M., Burton C.W., Chakraborty R. Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. J. Nurse Pract. 2022;18:335&#x2013;338. doi: 10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="pubmed">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M.J. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence. Immunol. Allergy Clin. N. Am. 2018;38:469&#x2013;481. doi: 10.1016/j.iac.2018.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2018.04.002</ArticleId><ArticleId IdType="pmc">PMC6049091</ArticleId><ArticleId IdType="pubmed">30007464</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun S., Storan A., Myers B. Mast cell activation syndrome and the link with long COVID. Br. J. Hosp. Med. 2022;83:1&#x2013;10. doi: 10.12968/hmed.2022.0123.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/hmed.2022.0123</ArticleId><ArticleId IdType="pubmed">35938771</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolarz B., Szy&#x142;&#x142;o K., Romanowicz H. Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature) Int. J. Mol. Sci. 2021;22:10554. doi: 10.3390/ijms221910554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910554</ArticleId><ArticleId IdType="pmc">PMC8508982</ArticleId><ArticleId IdType="pubmed">34638893</ArticleId></ArticleIdList></Reference><Reference><Citation>Knific T., Fishman D., Vogler A., Gst&#xf6;ttner M., Wenzl R., Peterson H., Ri&#x17e;ner T.L. Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls. Sci. Rep. 2019;9:16738. doi: 10.1038/s41598-019-52899-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52899-8</ArticleId><ArticleId IdType="pmc">PMC6853932</ArticleId><ArticleId IdType="pubmed">31723213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylikorkala O., Dawood M.Y. New concepts in dysmenorrhea. Am. J. Obstet. Gynecol. 1978;130:833&#x2013;847. doi: 10.1016/0002-9378(78)90019-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(78)90019-4</ArticleId><ArticleId IdType="pubmed">25021</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcikowska Z., Rajkowska-Labon E., Grzybowska M.E., Hansdorfer-Korzon R., Zorena K. Inflammatory Markers in Dysmenorrhea and Therapeutic Options. Int. J. Environ. Res. Public Health. 2020;17:1191. doi: 10.3390/ijerph17041191.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17041191</ArticleId><ArticleId IdType="pmc">PMC7068519</ArticleId><ArticleId IdType="pubmed">32069859</ArticleId></ArticleIdList></Reference><Reference><Citation>Guimar&#xe3;es I., P&#xf3;voa A.M. Primary Dysmenorrhea: Assessment and Treatment. Rev. Bras. Ginecol. Obstet. 2020;42:501&#x2013;507. doi: 10.1055/s-0040-1712131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1712131</ArticleId><ArticleId IdType="pmc">PMC10309238</ArticleId><ArticleId IdType="pubmed">32559803</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacovides S., Avidon I., Baker F.C. What we know about primary dysmenorrhea today: A critical review. Hum. Reprod. Update. 2015;21:762&#x2013;778. doi: 10.1093/humupd/dmv039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/dmv039</ArticleId><ArticleId IdType="pubmed">26346058</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K., Hirose M., Furukawa S., Hayakawa H., Kimura E. Changes in Hemodynamics and Bradykinin Concentration in Coronary Sinus Blood in Experimental Coronary Artery Occlusion. Jpn. Heart J. 1977;18:679&#x2013;689. doi: 10.1536/ihj.18.679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.18.679</ArticleId><ArticleId IdType="pubmed">303709</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch M., Wendorf M., Dendorfer A., Wolfrum S., Schulze K., Spillmann F., Schultheiss H.-P., Tsch&#xf6;pe C. Cardiac kinin level in experimental diabetes mellitus: Role of kininases. Am. J. Physiol. Circ. Physiol. 2003;285:H418&#x2013;H423. doi: 10.1152/ajpheart.00677.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00677.2002</ArticleId><ArticleId IdType="pubmed">12637359</ArticleId></ArticleIdList></Reference><Reference><Citation>Linz W., Wiemer G., Sch&#xf6;lkens B.A. Role of Kinins in the Pathophysiology of Myocardial Ischemia: In Vitro and In Vivo Studies. Diabetes. 1996;45:S51&#x2013;S58. doi: 10.2337/diab.45.1.S51.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diab.45.1.S51</ArticleId><ArticleId IdType="pubmed">8529801</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H.-L., Chen S.-R., Scicli G.M., Carretero O.A. Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning. Am. J. Physiol. Circ. Physiol. 2000;279:H116&#x2013;H121. doi: 10.1152/ajpheart.2000.279.1.H116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2000.279.1.H116</ArticleId><ArticleId IdType="pubmed">10899048</ArticleId></ArticleIdList></Reference><Reference><Citation>Staszewska-Barczak J., Ferreira S.H., Vane J.R. An excitatory nociceptive cardiac reflex elicited by bradykinin and potentiated by prostaglandins and myocardial ischaemia. Cardiovasc. Res. 1976;10:314&#x2013;327. doi: 10.1093/cvr/10.3.314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/10.3.314</ArticleId><ArticleId IdType="pubmed">954016</ArticleId></ArticleIdList></Reference><Reference><Citation>Stebbins C.L., Carretero O.A., Mindroiu T., Longhurst J.C. Bradykinin release from contracting skeletal muscle of the cat. J. Appl. Physiol. 1990;69:1225&#x2013;1230. doi: 10.1152/jappl.1990.69.4.1225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1990.69.4.1225</ArticleId><ArticleId IdType="pubmed">2124582</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2021;19:162. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType="pmc">PMC8058748</ArticleId><ArticleId IdType="pubmed">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bynke A., Julin P., Gottfries C.-G., Heidecke H., Scheibenbogen C., Bergquist J. Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients&#x2014;A validation study in plasma and cerebrospinal fluid from two Swedish cohorts. Brain Behav. Immun. Health. 2020;7:100107. doi: 10.1016/j.bbih.2020.100107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100107</ArticleId><ArticleId IdType="pmc">PMC8474431</ArticleId><ArticleId IdType="pubmed">34589868</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A., Shoenfeld Y. Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants. Autoimmun. Rev. 2023;22:103230. doi: 10.1016/j.autrev.2022.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103230</ArticleId><ArticleId IdType="pubmed">36347462</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Dyspnea in Post-COVID Syndrome following Mild Acute COVID-19 Infections: Potential Causes and Consequences for a Therapeutic Approach. Medicina. 2022;58:419. doi: 10.3390/medicina58030419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58030419</ArticleId><ArticleId IdType="pmc">PMC8951558</ArticleId><ArticleId IdType="pubmed">35334595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C., Paul F. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Transl. Med. 2021;19:471. doi: 10.1186/s12967-021-03143-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03143-3</ArticleId><ArticleId IdType="pmc">PMC8607226</ArticleId><ArticleId IdType="pubmed">34809664</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., Grabowski P., Heidecke H., Bauer S., Hanitsch L.G., Wittke K., Meisel C., Reinke P., Volk H.-D., Fluge &#xd8;., et al. Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav. Immun. 2016;52:32&#x2013;39. doi: 10.1016/j.bbi.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe N., Toyama H., Ejima Y., Saito K., Tamada T., Yamauchi M., Kazama I. &#x3b1;1-Adrenergic Receptor Blockade by Prazosin Synergistically Stabilizes Rat Peritoneal Mast Cells. BioMed Res. Int. 2020;2020:3214186. doi: 10.1155/2020/3214186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/3214186</ArticleId><ArticleId IdType="pmc">PMC7243011</ArticleId><ArticleId IdType="pubmed">32461978</ArticleId></ArticleIdList></Reference><Reference><Citation>MC van Campen C., Rowe P.C., Visser F.C. Reductions in Cerebral Blood Flow Can Be Provoked by Sitting in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Healthcare. 2020;8:394. doi: 10.3390/healthcare8040394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8040394</ArticleId><ArticleId IdType="pmc">PMC7712289</ArticleId><ArticleId IdType="pubmed">33050553</ArticleId></ArticleIdList></Reference><Reference><Citation>Petra A.I., Panagiotidou S., Stewart J.M., Conti P., Theoharides T.C. Spectrum of mast cell activation disorders. Expert Rev. Clin. Immunol. 2014;10:729&#x2013;739. doi: 10.1586/1744666X.2014.906302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/1744666X.2014.906302</ArticleId><ArticleId IdType="pubmed">24784142</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Tsilioni I., Ren H. Recent advances in our understanding of mast cell activation&#x2014;Or should it be mast cell mediator disorders? Expert Rev. Clin. Immunol. 2019;15:639&#x2013;656. doi: 10.1080/1744666X.2019.1596800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2019.1596800</ArticleId><ArticleId IdType="pmc">PMC7003574</ArticleId><ArticleId IdType="pubmed">30884251</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueff A., Dray A. Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience. 1993;54:527&#x2013;535. doi: 10.1016/0306-4522(93)90272-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(93)90272-H</ArticleId><ArticleId IdType="pubmed">8336834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.-J., Ahn Y.-C., Jang E.-S., Lee S.-W., Lee S.-H., Son C.-G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L., Zhang Y., Huang T., Zhou F., Xiong C., Liu Y., Zhai P., Wang G., Tan J., Jiao C., et al. A description of the current status of chronic fatigue syndrome and associated factors among university students in Wuhan, China. Front. Psychiatry. 2022;13:1047014. doi: 10.3389/fpsyt.2022.1047014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.1047014</ArticleId><ArticleId IdType="pmc">PMC9877457</ArticleId><ArticleId IdType="pubmed">36713904</ArticleId></ArticleIdList></Reference><Reference><Citation>Deumer U.-S., Varesi A., Floris V., Savioli G., Mantovani E., L&#xf3;pez-Carrasco P., Rosati G.M., Prasad S., Ricevuti G. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview. J. Clin. Med. 2021;10:4786. doi: 10.3390/jcm10204786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10204786</ArticleId><ArticleId IdType="pmc">PMC8538807</ArticleId><ArticleId IdType="pubmed">34682909</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Giannetti M.P., Weller E., Hamilton M.J., Castells M. Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy. Ann. Allergy Asthma Immunol. 2021;128:299&#x2013;306.e1. doi: 10.1016/j.anai.2021.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2021.10.006</ArticleId><ArticleId IdType="pubmed">34648976</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H., Szklarski M., Lorenz S., Sotzny F., Bauer S., Philippe A., Kedor C., Grabowski P., Lange T., Riemekasten G., et al. Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Clin. Med. 2021;10:3675. doi: 10.3390/jcm10163675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163675</ArticleId><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.-S., M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A., David P., Arnheim D., Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun. Rev. 2022;21:103071. doi: 10.1016/j.autrev.2022.103071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="pubmed">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C., Mardin C., Lucio M., Wallukat G., Hoffmanns J., Schr&#xf6;der T., Raith F., Rogge L., Heltmann F., Moritz M., et al. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int. J. Mol. Sci. 2022;23:7209. doi: 10.3390/ijms23137209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen E., Sakr A.M., Jespersen L.T. Studies on the Effect of Histamine in Isolated Human Pulmonary Arteries and Veins. Acta Pharmacol. Toxicol. 2009;54:86&#x2013;93. doi: 10.1111/j.1600-0773.1984.tb01900.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0773.1984.tb01900.x</ArticleId><ArticleId IdType="pubmed">6231804</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeffter P., Godfraind T. Histamine Receptors in the Smooth Muscle of Human Internal Mammary Artery and Saphenous Vein. Basic Clin. Pharmacol. Toxicol. 1989;64:64&#x2013;71. doi: 10.1111/j.1600-0773.1989.tb00603.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0773.1989.tb00603.x</ArticleId><ArticleId IdType="pubmed">2755913</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana J., Schwinghamer J., Young S. Direct effect of histamine on arterial and venous resistance in isolated dog hindlimb. Am. J. Physiol. Content. 1968;214:494&#x2013;505. doi: 10.1152/ajplegacy.1968.214.3.494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplegacy.1968.214.3.494</ArticleId><ArticleId IdType="pubmed">5638981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dachman W.D., Bedarida G., Blaschke T.F., Hoffman B.B. Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J. Allergy Clin. Immunol. 1994;93:606&#x2013;614. doi: 10.1016/S0091-6749(94)70072-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-6749(94)70072-9</ArticleId><ArticleId IdType="pubmed">8151062</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller-Schweinitzer E. On the pharmacology of venous smooth muscle from dog and man. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 1979;106:690&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">94863</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuru H., Kohno S., Iwata M., Shigei T. Characterization of histamine receptors in isolated rabbit veins. Experiment. 1987;243:696&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">2960796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergner M., Gr&#xe4;ser T., Handschuk L., Tiedt N. Vasomotor tone of isolated porcine coronary veins in response to acetylcholine, noradrenaline, and histamine. Biomed. Biochim. Acta. 1988;47:775&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">3240307</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiuchi K., Farkas J., Natelson B.H. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin. Physiol. Funct. Imaging. 2006;26:83&#x2013;86. doi: 10.1111/j.1475-097X.2006.00649.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-097X.2006.00649.x</ArticleId><ArticleId IdType="pubmed">16494597</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C.M.C., Rowe P.C., Visser F.C. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients. Clin. Neurophysiol. Pract. 2021;6:245&#x2013;255. doi: 10.1016/j.cnp.2021.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2021.09.001</ArticleId><ArticleId IdType="pmc">PMC8505270</ArticleId><ArticleId IdType="pubmed">34667909</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z.Y., Barnden L.R., Kwiatek R.A., Bhuta S., Hermens D.F., Lagopoulos J. Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systematic review. J. Transl. Med. 2020;18:335. doi: 10.1186/s12967-020-02506-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02506-6</ArticleId><ArticleId IdType="pmc">PMC7466519</ArticleId><ArticleId IdType="pubmed">32873297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z.Y., Finegan K., Bhuta S., Ireland T., Staines D.R., Marshall-Gradisnik S.M., Barnden L.R. Brain function characteristics of chronic fatigue syndrome: A task fMRI study. NeuroImage Clin. 2018;19:279&#x2013;286. doi: 10.1016/j.nicl.2018.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.04.025</ArticleId><ArticleId IdType="pmc">PMC6051500</ArticleId><ArticleId IdType="pubmed">30035022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Sadato N., Okada T., Mizuno K., Sasabe T., Tanabe H.C., Saito D.N., Onoe H., Kuratsune H., Watanabe Y. Reduced responsiveness is an essential feature of chronic fatigue syndrome: A fMRI study. BMC Neurol. 2006;6:9. doi: 10.1186/1471-2377-6-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-6-9</ArticleId><ArticleId IdType="pmc">PMC1397862</ArticleId><ArticleId IdType="pubmed">16504053</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanasila L., Diviani D. Protein-Protein Interactions at the Adrenergic Receptors. Curr. Drug Targets. 2012;13:15&#x2013;27. doi: 10.2174/138945012798868489.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138945012798868489</ArticleId><ArticleId IdType="pmc">PMC3290771</ArticleId><ArticleId IdType="pubmed">21777184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeijmakers J.G., Merkies I.S., Faber C.G. Small fiber neuropathies: Expanding their etiologies. Curr. Opin. Neurol. 2022;35:545&#x2013;552. doi: 10.1097/WCO.0000000000001103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001103</ArticleId><ArticleId IdType="pubmed">35950732</ArticleId></ArticleIdList></Reference><Reference><Citation>Brag&#xe9;e B., Michos A., Drum B., Fahlgren M., Szulkin R., Bertilson B.C. Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Neurol. 2020;11:828. doi: 10.3389/fneur.2020.00828.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00828</ArticleId><ArticleId IdType="pmc">PMC7485557</ArticleId><ArticleId IdType="pubmed">32982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulens M., Bruyninckx F., Dankaerts W., Rasschaert R., De Mulder P., Stalmans I., Vansant G., Bervoets C. High Prevalence of Perineural Cysts in Patients with Fibromyalgia and Chronic Fatigue Syndrome. Pain Med. 2021;22:883&#x2013;890. doi: 10.1093/pm/pnaa410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnaa410</ArticleId><ArticleId IdType="pubmed">33260218</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>